QPharma, a provider of compliance and commercial services to the life sciences industry, has acquired Qforma, Inc., a Morris Plains-based firm that offers healthcare analytics, predictive modeling, and product launch services to life science companies.

The acquisition expands QPharma’s Key Opinion Leader (KOL) identification, influence mapping, and analytics services, and its headcount by 10%, with new sales, strategy, and technology personnel based throughout the U.S. The Qforma brand will be phased out, and the company will continue to operate as QPharma.  

“The purchase of Qforma is a natural progression of the incremental growth strategy that has served QPharma well in the past two decades,” said QPharma president and chief executive officer Patrick Den Boer. “The outstanding technology platform and solution base they have built is a perfect complement to QPharma’s suite of business intelligence tools.”

“We are pleased to see this transaction come to fruition,” added Inder Tallur, managing director of BelHealth. “We believe this acquisition will enable QPharma to deliver outstanding value-added services, to the benefit of its growing roster of valued clients.”